Catalyst
Slingshot members are tracking this event:
Ironwood (IRWD) Expects to Initiate Phase 3 Trial Evaluating CR1 in IBS-C in the Second Half of 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| IRWD |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 16, 2018
Occurred Source:
https://seekingalpha.com/news/3370247-ironwood-launches-late-stage-study-linaclotide-ibs-c-shares-3-percent-premarket
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 3, Cr1, Ibs-c, Trial Initiation
